A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman

Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Kaishi, Matsuo, Takashi, Ishimatsu, Takashi, Fukae, Atsuki, Hamamoto, Takuro, Oku, Koji, Ito, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445258/
https://www.ncbi.nlm.nih.gov/pubmed/36093466
http://dx.doi.org/10.1002/ccr3.6161
_version_ 1784783389650321408
author Otsuka, Kaishi
Matsuo, Takashi
Ishimatsu, Takashi
Fukae, Atsuki
Hamamoto, Takuro
Oku, Koji
Ito, Masahiro
author_facet Otsuka, Kaishi
Matsuo, Takashi
Ishimatsu, Takashi
Fukae, Atsuki
Hamamoto, Takuro
Oku, Koji
Ito, Masahiro
author_sort Otsuka, Kaishi
collection PubMed
description Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the second dose of BNT162b2 COVID‐19 vaccine. Steroid pulse therapy was effective.
format Online
Article
Text
id pubmed-9445258
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94452582022-09-09 A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman Otsuka, Kaishi Matsuo, Takashi Ishimatsu, Takashi Fukae, Atsuki Hamamoto, Takuro Oku, Koji Ito, Masahiro Clin Case Rep Case Report Coronavirus disease 2019 (COVID‐19) vaccination is reportedly safe and effective. The histologic features of post‐COVID‐19 vaccination myocarditis are unknown. We present a case of a 77‐year‐old Japanese woman diagnosed with eosinophilic myocarditis using endomyocardial biopsy, 7 days after the second dose of BNT162b2 COVID‐19 vaccine. Steroid pulse therapy was effective. John Wiley and Sons Inc. 2022-09-05 /pmc/articles/PMC9445258/ /pubmed/36093466 http://dx.doi.org/10.1002/ccr3.6161 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Otsuka, Kaishi
Matsuo, Takashi
Ishimatsu, Takashi
Fukae, Atsuki
Hamamoto, Takuro
Oku, Koji
Ito, Masahiro
A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
title A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
title_full A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
title_fullStr A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
title_full_unstemmed A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
title_short A case of BNT162b2 COVID‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
title_sort case of bnt162b2 covid‐19 vaccine‐associated fulminant myocarditis in a very elderly woman
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445258/
https://www.ncbi.nlm.nih.gov/pubmed/36093466
http://dx.doi.org/10.1002/ccr3.6161
work_keys_str_mv AT otsukakaishi acaseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT matsuotakashi acaseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT ishimatsutakashi acaseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT fukaeatsuki acaseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT hamamototakuro acaseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT okukoji acaseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT itomasahiro acaseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT otsukakaishi caseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT matsuotakashi caseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT ishimatsutakashi caseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT fukaeatsuki caseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT hamamototakuro caseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT okukoji caseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman
AT itomasahiro caseofbnt162b2covid19vaccineassociatedfulminantmyocarditisinaveryelderlywoman

Ejemplares similares